1. Home
  2. NMFC vs MDXG Comparison

NMFC vs MDXG Comparison

Compare NMFC & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMFC
  • MDXG
  • Stock Information
  • Founded
  • NMFC 2010
  • MDXG 2006
  • Country
  • NMFC United States
  • MDXG United States
  • Employees
  • NMFC N/A
  • MDXG N/A
  • Industry
  • NMFC Finance/Investors Services
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • NMFC Finance
  • MDXG Health Care
  • Exchange
  • NMFC Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • NMFC 1.2B
  • MDXG 1.1B
  • IPO Year
  • NMFC 2011
  • MDXG N/A
  • Fundamental
  • Price
  • NMFC $11.38
  • MDXG $9.14
  • Analyst Decision
  • NMFC Hold
  • MDXG Strong Buy
  • Analyst Count
  • NMFC 2
  • MDXG 5
  • Target Price
  • NMFC $11.50
  • MDXG $12.00
  • AVG Volume (30 Days)
  • NMFC 538.4K
  • MDXG 637.3K
  • Earning Date
  • NMFC 02-24-2025
  • MDXG 02-26-2025
  • Dividend Yield
  • NMFC 11.23%
  • MDXG N/A
  • EPS Growth
  • NMFC N/A
  • MDXG N/A
  • EPS
  • NMFC 1.04
  • MDXG 0.52
  • Revenue
  • NMFC $373,513,000.00
  • MDXG $342,804,000.00
  • Revenue This Year
  • NMFC $1.68
  • MDXG $9.56
  • Revenue Next Year
  • NMFC N/A
  • MDXG $9.19
  • P/E Ratio
  • NMFC $10.95
  • MDXG $17.54
  • Revenue Growth
  • NMFC 4.95
  • MDXG 10.93
  • 52 Week Low
  • NMFC $10.62
  • MDXG $5.47
  • 52 Week High
  • NMFC $13.10
  • MDXG $10.14
  • Technical
  • Relative Strength Index (RSI)
  • NMFC 54.76
  • MDXG 53.81
  • Support Level
  • NMFC $10.80
  • MDXG $8.50
  • Resistance Level
  • NMFC $11.43
  • MDXG $9.71
  • Average True Range (ATR)
  • NMFC 0.15
  • MDXG 0.29
  • MACD
  • NMFC 0.04
  • MDXG -0.02
  • Stochastic Oscillator
  • NMFC 92.06
  • MDXG 52.89

About NMFC New Mountain Finance Corporation

New Mountain Finance Corp is a closed-end, non-diversified management investment company. It invests in equity interests such as preferred stock, common stock, warrants, or options received in connection with debt investments or may include direct investment in the equity of private companies. The company's investment objective is to generate current income and capital appreciation through sourcing and origination of debt securities at all levels of the capital structure, including first and second-lien debt, notes, bonds, and mezzanine securities.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: